CHAPTER 1 INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2 RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3 MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4 MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Availability of big data in the life science industry
4.1.2. Increasing adoption of analytics solutions in clinical trials
4.1.3. Need for improved data standardization
4.2. Market Restraints & Challenges
4.2.1. Data privacy issue
4.2.2. Data integration in the life science ecosystem
4.3. Market Opportunities
4.3.1. Increasing focus on value-based medicine
4.3.2. Use of big data analytics to increase R&D productivity
CHAPTER 5 GLOBAL LIFE SCIENCE ANALYTICS MARKET– BY TYPE
5.1. Introduction
5.2. Descriptive Analytics
5.3. Predictive Analytics
5.4. Prescriptive Analytics
CHAPTER 6 GLOBAL LIFE SCIENCE ANALYTICS MARKET– BY COMPONENT
6.1. Introduction
6.2. Software
6.3. Services
7 GLOBAL LIFE SCIENCE ANALYTICS MARKET– BY DELIVERY MODEL
7.1 Introduction
7.2 On-Premise Delivery Models
7.3 On-Demand Delivery Models
CHAPTER 8 GLOBAL LIFE SCIENCE ANALYTICS MARKET– BY APPLICATION
8.1. Introduction
8.2. Research & Development
8.3. Sales and Marketing Support
8.4. Regulatory Compliance
8.5. Supply Chain Analytics
8.6. Pharmacovigilance
CHAPTER 9 GLOBAL LIFE SCIENCE ANALYTICS MARKET– BY END USER
9.1. Introduction
9.2. Pharmaceutical and Biotechnology Companies
9.3. Medical Device Companies
9.4. Research Centers
9.5. Third-Party Administrators
CHAPTER 10 GLOBAL LIFE SCIENCE ANALYTICS MARKET- BY GEOGRAPHY
10.1. Introduction
10.2. North America
10.2.1. U.S.
10.2.2. Canada
10.2.3. Mexico
10.2.4. Costa Rica
10.3. South America
10.3.1. Brazil
10.3.2. Argentina
10.3.3. Chile
10.3.4. Columbia
10.3.5. Others
10.4. Europe
10.4.1. U.K.
10.4.2. Germany
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Russia
10.4.7. Netherlands
10.4.8. Switzerland
10.4.9. Poland
10.4.10. Others
10.5. APAC
10.5.1. China
10.5.2. Japan
10.5.3. India
10.5.4. South Korea
10.5.5. Australia & New Zealand
10.5.6. Malaysia
10.5.7. Singapore
10.5.8. Others
10.6. Middle East & Africa
10.6.1. UAE
10.6.2. Saudi Arabia
10.6.3. Iran
10.6.4. Iraq
10.6.5. Qatar
10.6.6. South Africa
10.6.7. Algeria
10.6.8. Morocco
10.6.9. Nigeria
10.6.10. Egypt
10.6.11. Others
CHAPTER 11 GLOBAL LIFE SCIENCE ANALYTICS MARKET- COMPANY
PROFILES
11.1. Introduction
11.2. SAS Institute Inc.
11.3. IBM Corporation
11.4. Oracle Corporation
11.5. Quintiles, Inc.
11.6. Accenture
11.7. Cognizant
11.8. MaxisIT Inc
11.9. Scio Health Analytics
11.10. Take Solutions
11.11. Wipro Limited
11.12. IQVIA
CHAPTER 12 GLOBAL LIFE SCIENCE ANALYTICS MARKET- COMPETITIVE
LANDSCAPE
12.1. Market Share Analysis
12.2. Strategies adopted by top companies
12.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 13 MARKET INSIGHTS
13.1. Industry Experts Insights
13.2. Analysts Opinions
13.3. Investment Opportunities
CHAPTER 14 APPENDIX
14.1. List of Tables
14.2. List of Figures
